Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
A clinical trial update for ICP-022 in systemic lupus erythematosus across Phase 1 and Phase 2 has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) [Phase 3]
Phase 3 trial update for baricitinib in systemic lupus erythematosus (SLE) completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: JBT-101 in Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial of JBT-101 in systemic lupus erythematosus has been completed with results posted.
-
FDA approval · 2022-11-16FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for mycophenolate mofetil from Concord Biotech Limited.
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus [Phase 2]
Phase 2 trial evaluating BMS-986165 in systemic lupus erythematosus has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-07-26FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for BENLYSTA (belimumab) from GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus [Phase 1, Phase 2]
A clinical trial update for CM313 injection in systemic lupus erythematosus across Phase 1 and Phase 2.
-
FDA approval · 2022-07-11FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for hydroxychloroquine sulfate from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Belimumab In Early Systemic Lupus Erythematosus [Phase 4]
Phase 4 clinical trial update for belimumab in early systemic lupus erythematosus has completed.
-
FDA approval · 2022-07-07FDA Approved: HYDROXYCHLOROQUINE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for HYDROXYCHLOROQUINE from Chartwell RX, LLC under an ANDA, making a generic version available.
-
CLINICAL_TRIALS trial_result · 2022-07-07Clinical Trial Update: A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis [Phase 2]
Phase 2 clinical trial update for laquinimod in active lupus arthritis (systemic lupus erythematosus).
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients [Phase 2]
Phase 2 clinical trial evaluating vitamin D and curcumin piperine for reducing disease activity and cytokine levels in systemic lupus erythe…
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Aerobic Exercise in Women With Systemic Lupus Erythematosus [NA]
Clinical trial investigating aerobic exercise in women with systemic lupus erythematosus has been terminated; results posted.
-
FDA approval · 2022-05-03FDA Approved: PLAQUENIL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for Plaquenil (hydroxychloroquine sulfate) submitted by Advanz Pharma (US) Corp. This action constit…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE [Phase 3]
Phase 3 trial BLISS-BELIEVE evaluated belimumab in combination with rituximab for adults with systemic lupus erythematosus; the study comple…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients . [Phase 3]
A Phase 3 trial evaluating the effect of cholecalciferol (vitamin D3) supplementation on disease activity and quality of life in systemic lu…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus [Phase 3]
Phase 3 clinical trial investigating belimumab plus low-dose IL-2 for systemic lupus erythematosus, evaluating efficacy and immunological ou…
-
CLINICAL_TRIALS trial_result · 2022-03-22Clinical Trial Update: Women Empowered to Live With Lupus Study [NA]
Emory University’s study on women living with systemic lupus erythematosus has completed and posted results on March 22, 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE [Phase 3]
A Phase 3 trial evaluating cyclophosphamide and hydroxychloroquine for thrombocytopenia in systemic lupus erythematosus was terminated.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care [Phase 1, Phase 2]
Phase 1/2 trial update for BOS161721 in systemic lupus erythematosus completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus [Phase 3]
A Phase 3 study of ustekinumab in active systemic lupus erythematosus was terminated, with results publicly posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis [Phase 2]
Phase 2 study of laquinimod in participants with active lupus nephritis has completed; results posted in 2022.
-
FDA approval · 2022-01-14FDA Approved: SOVUNA — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved SOVUNA (hydroxychloroquine sulfate) under an original application by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus [Phase 1]
Phase 1 trial evaluating HIV-1 gp120 protein vaccine in HIV-uninfected adults with quiescent systemic lupus erythematosus has completed with…
-
CLINICAL_TRIALS research · 2021-12-16Clinical Trial Update: Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases [Phase 4]
A Phase 4 trial evaluating the relevance of monitoring blood and salivary levels of drugs used in rheumatic autoimmune diseases, including S…